- Home
- VOR vs QSI Comparison
VOR vs QSI Comparison
Compare VOR & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- QSI
- Stock Information
- Founded
- VOR 2015
- QSI 2013
- Country
- VOR United States
- QSI United States
- Employees
- VOR N/A
- QSI N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- VOR Health Care
- QSI Health Care
- Exchange
- VOR Nasdaq
- QSI Nasdaq
- Market Cap
- VOR 261.0M
- QSI 226.8M
- IPO Year
- VOR 2021
- QSI N/A
- Fundamental
- Price
- VOR $33.79
- QSI $1.79
- Analyst Decision
- VOR Buy
- QSI Strong Buy
- Analyst Count
- VOR 6
- QSI 3
- Target Price
- VOR $78.00
- QSI $2.38
- AVG Volume (30 Days)
- VOR 447.4K
- QSI 12.5M
- Earning Date
- VOR 11-06-2025
- QSI 11-11-2025
- Dividend Yield
- VOR N/A
- QSI N/A
- EPS Growth
- VOR N/A
- QSI N/A
- EPS
- VOR N/A
- QSI N/A
- Revenue
- VOR N/A
- QSI $3,412,000.00
- Revenue This Year
- VOR N/A
- QSI N/A
- Revenue Next Year
- VOR N/A
- QSI $219.33
- P/E Ratio
- VOR N/A
- QSI N/A
- Revenue Growth
- VOR N/A
- QSI 100.47
- 52 Week Low
- VOR $2.62
- QSI $0.61
- 52 Week High
- VOR $65.80
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- VOR 61.12
- QSI 67.26
- Support Level
- VOR $36.67
- QSI $1.44
- Resistance Level
- VOR $49.95
- QSI $1.61
- Average True Range (ATR)
- VOR 4.63
- QSI 0.17
- MACD
- VOR -0.51
- QSI 0.04
- Stochastic Oscillator
- VOR 34.22
- QSI 80.34
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.